| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207019C Multifunctional paster |
| 06/22/2005 | CN1207003C Minerals and crystals collecting bag for health caring of human body |
| 06/22/2005 | CN1206976C Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 06/22/2005 | CA2487107A1 Novel targets for obesity from skeletal muscle |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6909006 Invention provides cyclopropylindole compounds with structures that allow them to be joined to combinatorial chains, as well as combinatorial libraries containing cyclopropylindoles themselves |
| 06/21/2005 | US6909000 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
| 06/21/2005 | US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908916 C-5 modified indazolylpyrrolotriazines |
| 06/21/2005 | US6908914 Antipsychotic cyclic N-aralkylamines |
| 06/21/2005 | US6908902 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 06/21/2005 | US6908900 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 06/21/2005 | US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay |
| 06/21/2005 | US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 06/21/2005 | CA2382387C Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2231143C Farnesyl transferase inhibiting 2-quinolone derivatives |
| 06/21/2005 | CA2213339C Method of treating adenosine depletion |
| 06/21/2005 | CA2182303C Method of preparing a viral vector by homologous intermolecular recombination |
| 06/17/2005 | CA2479432A1 Thiazole derivatives |
| 06/16/2005 | WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative |
| 06/16/2005 | WO2005054216A1 Novel anticancer agent “sulcoxin” |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005037928A3 Compounds for dual photodiagnosis and therapy |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO1991001624A8 Use of calcium antagonists for treating scars |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131237 Indole derivatives |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131064 Administering powder or aerosol to nasal mucous membrane |
| 06/16/2005 | US20050131061 Angiogenesis inhibitors |
| 06/16/2005 | US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes |
| 06/16/2005 | US20050131059 Anti-cancer combinations |
| 06/16/2005 | US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131040 Reacting losartan and poltassium compound in presence of water and aprotic solvent; salt formation |
| 06/16/2005 | US20050131035 Medicaments |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050131026 Bronchitis; chronic obstructive pulmonary disease; antihistamines; pneumonia |
| 06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 06/16/2005 | US20050131021 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 06/16/2005 | US20050131020 N-type calcium channel antagonists for the treatment of pain |
| 06/16/2005 | US20050131016 Chemical compounds |
| 06/16/2005 | US20050131015 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 06/16/2005 | US20050131009 Urea substituted imidazoquinolines |
| 06/16/2005 | US20050131003 Heterocyclic compounds |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130999 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130997 Pyrimidinone viral polymerase inhibitors |
| 06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 06/16/2005 | US20050130990 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130978 Novel crystal of quinoxalinedione derivative anhydride |
| 06/16/2005 | US20050130977 Inhibitors of akt activity |
| 06/16/2005 | US20050130975 Phthalazine, hydralazine derivative; antihypertensive; extended shell life |
| 06/16/2005 | US20050130972 Derivatives have a positive charge at the position corresponding to the anomeric position of a pyranose ring; active-site specific chaperones for mutant glucocerebrosidase |
| 06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
| 06/16/2005 | US20050130965 Inhibitors of p38 kinase |
| 06/16/2005 | US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis |
| 06/16/2005 | US20050130963 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 06/16/2005 | US20050130962 Seratonin receptor antagonist; central nervous system disorders; halo phenyl substituents |
| 06/16/2005 | US20050130945 Preventing recurrence of breast cancer with atamestane and toremifene |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/16/2005 | US20050130929 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis |
| 06/16/2005 | US20050130130 Killer cell activatory receptor ligand for use in diagnosis, prevention and treatment of infection, cell proliferative, autoimmune and arthritic disorders |
| 06/16/2005 | US20050129786 Topical composition having undifferentiated plant seed cells and method for using same |
| 06/16/2005 | US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 06/16/2005 | US20050129774 Mixture with surfactant and another drug; analgesics; antiinflammatory agents |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129723 Skin care composition that mediates cell to cell communication |
| 06/16/2005 | US20050129694 At least one (SEK) kinase inhibitor that acts in an synergistic manner to those inhibiting the virus multiplication for the Raf/MEK/ERK signal transmission path; influenza viricides |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | CA2546445A1 Use of beta-lapachone for protecting against radiation injury |
| 06/15/2005 | EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 06/15/2005 | EP1541677A1 Novel proteins and use thereof |
| 06/15/2005 | EP1541673A1 Novel probiotics for pet food applications |
| 06/15/2005 | EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2005 | EP1541585A1 Cxcr4 antagonist and use thereof |
| 06/15/2005 | EP1541581A1 4 -thionucleotide |
| 06/15/2005 | EP1541580A1 Sulfotransferase inhibitors |
| 06/15/2005 | EP1541579A1 Produrg, medicinal utilization thereof and process for producing the same |
| 06/15/2005 | EP1541578A1 Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides |
| 06/15/2005 | EP1541576A1 Furoisoquinoline derivative and use thereof |
| 06/15/2005 | EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient |